✦ LIBER ✦

Novel therapeutic targets

✍ Scribed by P. Geppetti; M. Trevisani; P. Nicoletti; J. G. Capone

Publisher: Springer Milan
Year: 2006
Tongue: English
Weight: 44 KB
Volume: 27
Category: Article
ISSN: 1590-1874
DOI: 10.1007/s10072-006-0583-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel therapeutic targets along the Th17

Novel therapeutic targets along the Th17 pathway

✍ Wenjun Ouyang; Ellen Filvaroff; Yan Hu; Jane Grogan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

Nuclear EGFR as Novel Therapeutic Target

✍ Klaus Dittmann; Claus Mayer; H. Peter Rodemann 📂 Article 📅 2009 🏛 Springer 🌐 German ⚖ 278 KB

Novel targets with potential therapeutic

Novel targets with potential therapeutic applications in osteosarcoma

✍ Chand Khanna 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 267 KB

NAD+-dependent histone deacetylases (sir

NAD+-dependent histone deacetylases (sirtuins) as novel therapeutic targets

✍ Jörg Schemies; Urszula Uciechowska; Wolfgang Sippl; Manfred Jung 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

Histone deacetylases (HDACs) are enzymes that cleave off acetyl groups from acetyl-lysine residues in histones and various nonhistone proteins. Four different classes of HDACs have been identified in humans so far. Although classes I, II, and IV are zinc-dependent amidohydrolases, class III HDACs de

Proteases as therapeutic targets

✍ Charles S. Craik; Christine Debouek 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 114 KB

Adipocytokines: Emerging therapeutic tar

Adipocytokines: Emerging therapeutic targets

✍ Yuji Matsuzawa 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 141 KB